Lymphapar Liquid
NDC Package 44911-0456-1
Package Information
Lymphapar (echinacea (angustifolia), lymph node (suis), phytolacca decandra, conium maculatum, ferrum iodatum, hepar sulphuris calcareum , kali muriaticum, lachesis mutus, silicea) liquids May temporarily relieve swollen tonsils or irritated throat and swollen irritated breasts prior to menses.****Claims based on traditional homeopathic practice, not accepted medical evidence. This formulation utilizes a liquid delivery system. Marketed by Energique, Inc., this product is identified by NDC 44911-0456.
Identification & Billing
Clinical Specifications
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 44911 - Energique, Inc.
- 44911-0456 - Lymphapar
- 44911-0456-1 - 30 mL in 1 BOTTLE, DROPPER
- 44911-0456 - Lymphapar
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 44911-0456-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Lymphapar, a human over the counter drug labeled by Energique, Inc.. This liquid is formulated for oral use and contains calcium sulfide; conium maculatum flowering top; echinacea angustifolia; ferrous iodide; lachesis muta venom; phytolacca americana root; potassium chloride; silicon dioxide; sus scrofa lymph as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energique, Inc. on May 14, 2018.
How is this Energique, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 44911045601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.